TriVascular2 Raises $30 Million
TriVascular, a Santa Rosa, Calif.-based developer of endovascular repair devices for treating abdominal aortic aneurysms, has raised $30 million in Series B funding. Return backers include New Enterprise Associates, Delphi Ventures, MPM Capital and Kearny Venture Partners. The company previously raised $65 million, part of which was used to purchase TriVascular from Boston Scientific (which itself had purchased the company from VCs Delphi and Kearny).
20 November 2009•2 mins read
